139 related articles for article (PubMed ID: 11668978)
21. Public-private partnerships: an overview.
Widdus R
Trans R Soc Trop Med Hyg; 2005 Oct; 99 Suppl 1():S1-8. PubMed ID: 16085172
[TBL] [Abstract][Full Text] [Related]
22. The role of university technology transfer operations in assuring access to medicines and vaccines in developing countries.
Nelsen L
Yale J Health Policy Law Ethics; 2003; 3(2):301-8. PubMed ID: 14577146
[No Abstract] [Full Text] [Related]
23. More drugs, less protection.
Nature; 2002 Sep; 419(6904):233. PubMed ID: 12239521
[No Abstract] [Full Text] [Related]
24. The great medicines scandal: access is not just about cost.
Waning BJ
BMJ; 2006 Jul; 333(7557):44. PubMed ID: 16809717
[No Abstract] [Full Text] [Related]
25. Building a medicine bank for Venezuela. AIDS treatment access.
AIDSlink; 1997; (43):5. PubMed ID: 12321757
[TBL] [Abstract][Full Text] [Related]
26. NIH forges R&D partnerships in developing countries.
Salicrup LA
Nat Biotechnol; 2007 Sep; 25(9):976-7. PubMed ID: 17846621
[No Abstract] [Full Text] [Related]
27. Playing God? Owning God?--Patenting and the human genome.
Kirby M
Univ N S W Law J; 2003; 26(3):770-81. PubMed ID: 16617531
[No Abstract] [Full Text] [Related]
28. Access to treatment in developing countries: a global issue of equity and human rights.
Thomas J
AIDS Anal Afr; 1998 Apr; 8(2):10-1, 15. PubMed ID: 12293619
[TBL] [Abstract][Full Text] [Related]
29. Spurious and counterfeit drugs: a growing industry in the developing world.
Gautam CS; Utreja A; Singal GL
Postgrad Med J; 2009 May; 85(1003):251-6. PubMed ID: 19520877
[TBL] [Abstract][Full Text] [Related]
30. U.S. is lone holdout on drug access vote.
AIDS Policy Law; 2003 Jan; 18(1):1. PubMed ID: 12569860
[No Abstract] [Full Text] [Related]
31. Implications of bilateral free trade agreements on access to medicines.
Correa CM
Bull World Health Organ; 2006 May; 84(5):399-404. PubMed ID: 16710551
[TBL] [Abstract][Full Text] [Related]
32. Deterring the importation of counterfeit pharmaceutical products.
Stearn DW
Food Drug Law J; 2004; 59(4):537-61. PubMed ID: 15875351
[No Abstract] [Full Text] [Related]
33. The responsibility of research universities to promote access to essential medicines.
't Hoen EF
Yale J Health Policy Law Ethics; 2003; 3(2):293-300. PubMed ID: 14577145
[No Abstract] [Full Text] [Related]
34. U.S. helps developing countries devise, upgrade EMS systems.
Tannenhaus N
Emerg Dep News; 1984 Sep; 6(9):3, 9. PubMed ID: 10267712
[No Abstract] [Full Text] [Related]
35. Uzbekistan drug airlift: a quantitative analysis of public/private collaboration.
Wertheimer AI; Santella TM; Arroyave VM
Pharm World Sci; 2005 Aug; 27(4):344-50. PubMed ID: 16228635
[TBL] [Abstract][Full Text] [Related]
36. [The fight against counterfeit medicines in Africa: experience and role of pharmacists].
Chauvé M
C R Biol; 2008 Dec; 331(12):982-5. PubMed ID: 19027699
[TBL] [Abstract][Full Text] [Related]
37. Counterfeiting and piracy of pharmaceuticals.
Grackin A
IEEE Eng Med Biol Mag; 2008; 27(6):66-9. PubMed ID: 19004698
[No Abstract] [Full Text] [Related]
38. UK leads initiative to drive down cost of drugs in poor countries.
Short R
BMJ; 2007 Apr; 334(7599):870. PubMed ID: 17463440
[No Abstract] [Full Text] [Related]
39. Cairo Conference, foreign aid overhaul heighten U.S. pop program visibility.
Wash Memo Alan Guttmacher Inst; 1994 Jan; (2):1-2. PubMed ID: 12318674
[TBL] [Abstract][Full Text] [Related]
40. Promoting public health and protecting consumers in a global economy: an overview of HHS/FDA's international activities.
Kelly DP; Bachorik LL
Food Drug Law J; 2005; 60(3):339-46. PubMed ID: 16304741
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
